Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial
Conclusions In patients with AF who underwent PCI, the edoxaban-based regimen, as compared with VKA-based regimen, provides consistent safety and similar efficacy for ischaemic events in patients with AF regardless of their clinical presentation.
Source: European Heart Journal - Category: Cardiology Source Type: research
More News: Angioplasty | Aspirin | Atrial Fibrillation | Bleeding | Cardiology | Coronary Angioplasty | Heart | Heart Attack | Ischemic Stroke | Percutaneous Coronary Intervention | Stroke | Thrombosis | Vitamin K | Vitamins